by Christos Evangelou, MSc, PhD – Medical Writer and Editor A collaborative effort involving universities and research institutes in China and Germany led to the development of a deep learning model trained on standard hematoxylin and eosin (H&E)-stained whole-slide images to predict tumor lactate metabolic status, a feature that is typically assessed using molecular profiling. The researchers validated the model across 13 cancer types and in an independent real-world cohort, and found that it accurately predicted tumor lactate metabolism from routine histology, providing a scalable and practical digital biomarker for metabolism-informed precision oncology. The study was published in Frontiers in Immunology. Study Rationale Lactate, the end product of [...]
Computational Pathology & AI
- Computational Pathology & AI
- Thought Leader Podcasts
- Computational Pathology & AI
- Conference Reports
- Community Contributions
Industry Headlines
Podcasts
The Latest Research
- Research & Development
More News
- All
- 10x Genomics
- 3DHistech
- AetherAI
- Aiforia
- Aiosyn
- Aira Matrix
- AIVIS
- Anatomic & Clinical Pathology
- Byte-Sized Literature
- Case Of The Month
- Cell-Carta
- Clinisys
- Community Contributions
- Computational Pathology & AI
- Conference Reports
- Deciphex
- Deep Bio
- Diagnexia
- Digital pathology
- Digital Pathology Place
- DigitCells
- eizo
- EVIDENT
- Fujifilm
- Histowiz
- Imagene
- Indica Labs
- Industry News
- Leica Biosystems
- Lumea
- Medica
- Micropix
- Mindpeak
- Modella AI
- Motic
- NationWide Labs
- Orchard Software
- Owkin
- Paige
- PathAI
- PathPresenter
- PathQA
- Philips
- Pramana
- Proscia
- Roche
- Saman Tree Medical
- Source Bioscience
- Spatial Biology
- SPIE Conference Mini Series
- Techcyte
- Thought Leader Podcasts
- TissueGnostics
- Tribun Health
- Ultivue
- Vivascope
- WSK Medical
Media Partners
The Latest…
Computational Pathology & AI
Thought Leader Podcasts
Podcasts
The conversation focuses on OYDN, an AI-powered computational pathology model developed through a collaboration between the TIA Centre and the University of Sheffield. Adam and Hanya discuss how the technology supports more objective diagnosis, improves risk stratification for patients at risk of developing oral cancer, and is helping uncover novel digital biomarkers that could shape future treatment strategies.
Thought Leader Podcasts
Latest Research
Industry News
Computational Pathology & AI
Who Do We Work With…
Our Media Partners
Commercial Partners
More News
Thought Leader Podcasts


























































































![Figure 1: Fine-tuning improves robustness and performance jointly. Each foundation model is shown before (open circle) and after (filled circle) fine-tuning. The x-axis is the average PathoROB robustness index over three datasets, where higher values indicate greater robustness; the y-axis is the normalized rank sum over the HEST, THUNDER and Patho-Bench benchmarks, rescaled to [0, 1] so that 1 corresponds to the best achievable performance.](https://www.pathologynews.com/wp-content/uploads/2020/07/embedding-figure-800x600-1.png)